Rob Reznick Comments on Case Concerning International Application of RICO

The Wall Street Journal
October.02.2015

Rob Reznick, a partner in Orrick's Washington, D.C. office, recently spoke to The Wall Street Journal about the Supreme Court’s decision to hear a case pursued by the European Commission and member countries presenting the question whether the Racketeer Influenced and Corrupt Organizations Act (RICO) should be applied extraterritorially, to conduct occurring in Europe. Rob is Managing Editor of The World in US Courts: Orrick's Quarterly Review of Decisions Applying US Law to Global Business and Cross-Border Activities.

Counting the case accepted by the Supreme Court for review, there are at least three different court interpretations of the racketeering statute’s international application. Given the nationwide service of process available for RICO claims, Rob characterized the current law a “forum shopper’s delight.” A decision by the Supreme Court is expected this term.

Related Lawyers

Robert Reznick Senior Counsel, Complex Litigation & Dispute Resolution, Antitrust & Competition

Washington, D.C.

See my bio

D:+1 202 339 8409
E: [email protected]

Practice:

Technology & Innovation Sector
Life Sciences Sector
Complex Litigation & Dispute Resolution
Antitrust & Competition
Intellectual Property

vCard

See full bio

Robert Reznick Senior Counsel

Washington, D.C.

He currently is national coordinating counsel for a major oil company in connection with its climate change litigation. He previously served as co-lead counsel to a major international pharmaceutical manufacturer in the defense of nationwide litigation challenging industry pricing practices.

Rob’s experience includes extensive work in antitrust and False Claims Act cases, claims alleging fraud, and agency enforcement actions. His pharmaceutical industry activities include service as outside counsel to and Corporate Secretary of the Pharmaceutical Security Institute, Inc., the industry’s not-for-profit trade organization dedicated to the fight against pharmaceutical counterfeiting.

He is Managing Editor of The World in U.S. Courts, Orrick’s quarterly review of court decisions addressing personal jurisdiction over non-U.S. parties and the extraterritorial application of U.S. law to global business and cross-border activities.

Rob also served two terms on the District of Columbia Bar’s Pro Bono standing committee. Before joining Orrick, he was a partner in Hughes Hubbard & Reed LLP and Clifford & Warnke, in Washington, D.C.

Related Areas

Litigation & IP

Markets

Washington, D.C.